Aragón-Niño I,
Cuesta-Urquía C, González-Martín-Moro J, Morán-Soto MJ, Pozo-Kreilinger JJ,
Pampín-Martinez MM, del Castillo-Pardo-de Vera JL, Cebrián-Carretero JL. HPV
infection in oral cancer, our experience: prevalence, clinical implications, and
current vaccination program in Spain. J Clin Exp Dent. 2023;15(7):e584-9.
doi:10.4317/jced.60514
https://doi.org/10.4317/jced.60514
__________
References
1.
Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Morphological and
immunohistochemical evidence suggesting human papillomavirus (HPV)
involvement in oral squamous cell carcinogenesis. Int J Oral Surg.1983;12:418-24. |
|
|
|
2.
Seijas-Tamayo R, Fernández-Mateos J, Adansa Klain JC, Mesía R, Pastor
Borgoñón M, Pérez-Ruiz E, et al. Epidemiological characteristics of a Spanish
cohort of patients diagnosed with squamous cell carcinoma of head and neck:
distribution of risk factors by tumor location. Clinical and Translational
Oncology. 2016;18:1114-22. |
|
|
|
3.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for
human papillomavirus-related and -unrelated oral squamous cell carcinomas in
the United States. Journal of Clinical Oncology. 2008;26:612-9. |
|
|
|
4.
Villagómez-Ortíz VJ, Paz-Delgadillo DE, Marino-Martínez I, Ceseñas-Falcón LÁ,
Sandoval-de la Fuente A, Reyes-Escobedo A. Prevalencia de infección por virus
del papiloma humano en carcinoma espinocelular de cavidad oral, orofaringe y
laringe. Cir Cir. 2016;84:363-8. |
|
|
|
5.
Nogues JC, Fassas S, Mulcahy C, Zapanta PE. Human papillomavirus-associated
head and neck cancer. Journal of the American Board of Family Medicine. American
Board of Family Medicine. 2021;34:832. |
|
|
|
6.
Tumban E. A current update on human papillomavirus-associated head and neck
cancers. Viruses. MDPI AG; 2019;11. |
|
|
|
7.
Sabatini ME, Chiocca S. Human papillomavirus as a driver of head and neck
cancers. British Journal of Cancer. Springer Nature. 2020;122:306-14. |
|
|
|
8.
Melo BA de C, Vilar LG, Oliveira NR de, Lima PO de, Pinheiro M de B,
Domingueti CP, et al. Human papillomavirus infection and oral squamous cell
carcinoma - a systematic review. Brazilian Journal of Otorhinolaryngology.
Elsevier Editora Ltda. 2021;87:346-52. |
|
|
|
9.
Chaitanya N, Allam N, Gandhi Babu D, Waghray S, Badam R, Lavanya R.
Systematic meta-analysis on association of human papilloma virus and oral
cancer. J Cancer Res Ther. 2016;12:969-74. |
|
|
|
10.
Kansy K, Thiele O, Freier K. The role of human papillomavirus in oral
squamous cell carcinoma: Myth and reality. Oral Maxillofac Surg. 2014;18:165-72. |
|
|
|
11.
Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human
papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer
Science. 2007;98:1505-11. |
|
|
|
12.
Shyamsundar V, Thangaraj SV, Krishnamurthy A, Vimal S, Kesavan P, Babu A, et
al. Exome Sequencing with Validations and Expression of p16/CDKN2A Shows no
Association with HPV in Oral Cancers. Asian Pacific Journal of Cancer
Prevention. 2022;23:191-200. |
|
|
|
13.
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, et al. HPV
DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a
systematic review and meta-analysis. Lancet Oncol. 2014;15:1319-31. |
|
|
|
14.
Santacroce L, di Cosola M, Bottalico L, Topi S, Charitos IA, Ballini A, et
al. Focus on hpv infection and the molecular mechanisms of oral
carcinogenesis. Viruses. MDPI AG. 2021;13. |
|
|
|
15.
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, et al. HPV
DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: A
systematic review and meta-analysis. Lancet Oncol. 2014;15:1319-31. |
|
|
|
16.
Lewis JS, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, et al.
Human papillomavirus testing in head and neck carcinomas guideline from the
college of American pathologists. Arch Pathol Lab Med. 2018;142:559-97. |
|
|
|
17.
Burd EM. Human papillomavirus laboratory testing: The changing paradigm. Clin
Microbiol Rev. 2016;29:291-319. |
|
|
|
18.
Valls-Ontañón A, Hernández-Losa J, Somoza Lopez de Haro R, Bellosillo-Paricio
B, Ramón y Cajal S, Bescós-Atín C, et al. Impact of human papilloma virus in
patients with oral and oropharyngeal squamous cell carcinomas. Med Clin
(Barc). 2019;152:174-80. |
|
|
|
19.
Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R, Clavero O, et
al. Human papillomavirus in premalignant oral lesions: No evidence of
association in a Spanish cohort. PLoS One. 2019;14. |
|
|
|
20.
Fiorillo L, Cervino G, Surace G, de Stefano R, Laino L, D'Amico C, et al.
Human Papilloma Virus: Current Knowledge and Focus on Oral Health. BioMed
Research International. Hindawi Limited. 2021;2021. |
|
|
|
21.
Giraldi L, Collatuzzo G, Hashim D, Franceschi S, Herrero R, Chen C, et al.
Infection with Human Papilloma Virus (HPV) and risk of subsites within the
oral cancer. Cancer Epidemiol. 2021;75. |
|
|
|
22.
van der Waal I. Oral potentially malignant disorders: Is malignant
transformation predictable and preventable? Med Oral Patol Oral Cir Bucal.
2014;19. |
|
|
|
23.
Lafaurie GI, Perdomo SJ, Buenahora MR, Amaya S, Díaz-Báez D. Human papilloma
virus: An etiological and prognostic factor for oral cancer? J Investig Clin
Dent. 2018;9:e12313. |
|
|
|
24.
Agrawal Y, Koch WM, Xiao W, Westra WH, Trivett AL, Symer DE, et al. Oral
human papillomavirus infection before and after treatment for human
papillomavirus 16-positive and human papillomavirus 16-negative head and neck
squamous cell carcinoma. Clinical Cancer Research. 2008;14:7143-50. |
|
|
|
25.
Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, et al.
Human papillomavirus and oral cancer: The international agency for research
on cancer multicenter study. J Natl Cancer Inst. 2003;95:1772-83. |
|
|
|
26.
Yete S, D'Souza W, Saranath D. High-Risk Human Papillomavirus in Oral Cancer:
Clinical Implications. Oncology (Switzerland). S. Karger AG. 2018;94:133-41. |
|
|
|
27.
Christianto S, Li KY, Huang TH, Su YX. The Prognostic Value of Human
Papilloma Virus Infection in Oral Cavity Squamous Cell Carcinoma: A
Meta-Analysis. Laryngoscope. John Wiley and Sons Inc. 2022;132:1760-70. |
|
|
|
28.
Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, et al. Human
papillomavirus-16 infection in advanced oral cavity cancer patients is
related to an increased risk of distant metastases and poor survival. PLoS
One. 2012;7. |
|
|
|
29.
Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, et al. Human
papillomavirus-16 infection in advanced oral cavity cancer patients is
related to an increased risk of distant metastases and poor survival. PLoS
One. 2012;7. |
|
|
|
30.
Arbyn M, Xu L, Simoens C, Martin-Hirsch PPL. Prophylactic vaccination against
human papillomaviruses to prevent cervical cancer and its precursors.
Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. 2018;2018. |
|
|
|
31.
Abel MK, Mann AK, Sonawane K, Kapp DS, Deshmukh AA, Chan JK. Prevalence of
Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US
Adults. JNCI Cancer Spectr. 2021;5. |
|
|
|
32.
Choi SE, Choudhary A, Huang J, Sonis S, Giuliano AR, Villa A. Increasing HPV
vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness
analysis. Tumour Virus Res. 2022;13. |